Congress Trades in Moderna, Inc. (MRNA)
4 members of Congress have disclosed trading MRNA.
Total trades
12
Purchases
2
Sales
10
Members
4
Est. volume
$134,502
Last traded
Apr 8, 2025
Want the fundamentals on MRNA?
MRNA stock analysis →
See Moderna, Inc.'s price, P/E, ROE and a free return calculator.
4 members of Congress have disclosed trading Moderna, Inc. (MRNA), with 12 transactions in total — 2 purchases and 10 sales worth an estimated $134,502 at range midpoints, leaning heavily toward selling. The most active MRNA trader is Marie Newman (9 disclosures). The most recent disclosed MRNA trade was on Apr 8, 2025. See our full MRNA fundamentals page for price, valuation and a return calculator.
Every disclosed MRNA trade
| Disclosed | Politician | Type | Amount | Traded | |
|---|---|---|---|---|---|
| Apr 8, 2025 | Rob Bresnahan | Sale | $1,001 - $15,000 | Apr 8, 2025 | filing ↗ |
| Feb 7, 2025 | Julie Johnson D | Sale | $1,001 - $15,000 | Jan 15, 2025 | filing ↗ |
| Mar 5, 2024 | Josh Gottheimer D | Sale | $1,001 - $15,000 | Feb 1, 2024 | filing ↗ |
| Mar 1, 2021 | Marie Newman | Sale | $1,001 - $15,000 | Jan 29, 2021 | filing ↗ |
| Mar 1, 2021 | Marie Newman | Sale | $1,001 - $15,000 | Jan 29, 2021 | filing ↗ |
| Mar 1, 2021 | Marie Newman | Sale | $15,001 | Jan 29, 2021 | filing ↗ |
| Mar 1, 2021 | Marie Newman | Sale | $15,001 | Jan 29, 2021 | filing ↗ |
| Feb 3, 2021 | Marie Newman | Sale | $1,001 - $15,000 | Jan 22, 2021 | filing ↗ |
| Feb 3, 2021 | Marie Newman | Purchase | $1,001 - $15,000 | Jan 22, 2021 | filing ↗ |
| Feb 3, 2021 | Marie Newman | Purchase | $1,001 - $15,000 | Jan 14, 2021 | filing ↗ |
| Feb 3, 2021 | Marie Newman | Sale | $1,001 - $15,000 | Jan 8, 2021 | filing ↗ |
| Feb 3, 2021 | Marie Newman | Sale | $15,001 - $50,000 | Jan 8, 2021 | filing ↗ |
Most active MRNA traders in Congress
MN
Marie Newman
9 trades
RB
Rob Bresnahan
1 trade
Julie Johnson
Democrat
1 trade
Josh Gottheimer
Democrat
1 trade
Julie Johnson
Democrat
1 trade
Josh Gottheimer
Democrat
1 trade
Source: US House Clerk Periodic Transaction Reports. Amounts are disclosed as ranges; estimates use range midpoints. Data may be delayed or contain filer errors. Not investment advice.